Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

PURPOSE: Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for treatment of multiple chronic pain disorders. We hypothesized that treatment of AIMSS with dul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Henry, N. Lynn, Unger, Joseph M., Schott, Anne F., Fehrenbacher, Louis, Flynn, Patrick J., Prow, Debra M., Sharer, Carl W., Burton, Gary V., Kuzma, Charles S., Moseley, Anna, Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Hershman, Dawn L., Wade, James L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2018
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805479/
https://ncbi.nlm.nih.gov/pubmed/29136387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6651
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller